# Nonclinical Safety Evaluation of Pediatric Drug Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a

> FDA guidance document: Nonclinical Safety Evaluation of Pediatric Drug Products. Issue date: February 15, 2006. Get complete insights and analysis.

---

## Details

- Title: Nonclinical Safety Evaluation of Pediatric Drug Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2006-02-15
- Last Changed: 2024-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/2003D-0001">2003D-0001</a>

## Related Documents

- [Role of HIV Drug Resistance Testing in Antiretroviral Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/role-of-hiv-drug-resistance-testing-in-antiretroviral-drug-development/b63afac3-86d1-45b1-bee0-b25944c92926)
- [Nonclinical Safety Evaluation of Drug or Biologic Combinations](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-drug-or-biologic-combinations/a7c3b200-9178-4944-81a0-27721e31a958)
- [Recommended Approaches to Integration of Genetic Toxicology Study Results](https://www.globalkeysolutions.net/guidances/guidance-document/recommended-approaches-to-integration-of-genetic-toxicology-study-results/9df3bcde-34b4-434c-9610-221248544f22)